Most early-stage cancers are found by accident. Too many are lost to follow-up.
In every busy health system, incidental findings sit buried in radiology reports and EHR data. Early indications of cancer can often slip through the cracks, leading to poorer outcomes and lost opportunities for curative care. Even when potentially suspicious anomalies are identified, the volume of manual administrative tasks required to manage them can generate more frustration than follow-up.
Eon’s platform and people empower you to close the gaps.
One enterprise platform. Not one-size-fits-all AI.
Eon’s unique clinical AI engines identify incidental findings with precision, streamline case review, and automate the management of follow-up—enabling you to catch and treat cancers earlier, at scale, without adding staff.
Your navigation team, multiplied.
Getting patients into care takes work—confirming findings, determining next steps, sending letters, and reaching out when patients don’t respond. Eon’s team takes tasks off your navigators’ plates so they can focus on high-value work and you can reach every patient.
We’ve helped shift the stages of outcomes at leading health systems — and we can for you too.
- 180% increase in cancers diagnosed in earlier stages
- 207% growth in robotic bronchoscopy volume
- 50% reduced time to treatment
- 4 months to achieve program ROI
- $3.44M in new direct margin generated
Visit us at AABIP 2026 (Booth 42) or online at www.eonhealth.com.
About Eon
Eon is a healthcare technology company helping health systems find patients at risk of cancer earlier and ensure they receive timely follow-up and longitudinal surveillance. Eon’s platform identifies incidental findings in radiology reports, tracks patients through completed care, and pairs technology with dedicated navigators who support care coordination and patient outreach. Having analyzed more than 500 million radiology reports, Eon serves more than 75 health systems across over 1,200 facilities.
